ABERNETHY MATT sold NBIX
March 4, 2026 · Form 4 insider transaction
ABERNETHY MATT sold 2,249 shares of Neurocrine Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as gift and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
2,249
Price
$0.00
Total value
N/A
InsiderABERNETHY MATT
RoleDirector
SecurityCommon Stock
Transaction codeG: Gift
Transaction dateMarch 4, 2026
Filing dateMarch 5, 2026
Shares owned after42,808
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction represents a gift/charitable contribution effective March 4, 2026. This is not a market transaction, thus no price has been reported. No value was received for the gifted shares.; Includes an aggregate of 176 shares purchased on February 27, 2026 from the Neurocrine Biosciences, Inc. 2018 Employee Stock Purchase Plan.